Equity Profile

LH

Labcorp Holdings Inc.

Health CareHealth Care Services$22.7B

Jul23Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Labcorp Holdings Inc. is a leading health care company that provides laboratory services and diagnostic testing....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability, and investors will look for continued growth in this area.

N/A

Revenue Growth

Revenue growth is essential for assessing the company's ability to expand its market share and maintain profitability.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

LH Q2-2026 Earnings Preview

Context

Company Snapshot

Labcorp Holdings Inc. is a leading health care company that provides laboratory services and diagnostic testing. With a market cap of $23 billion, Labcorp plays a crucial role in the health care sector by helping patients and physicians make informed decisions through accurate testing and analysis.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+2.88%

Avg Stock Reaction

+1.95%

Last Quarter Recap

In Q1-2026, Labcorp reported an EPS of $4.25, exceeding expectations by 3.81%. However, the stock experienced a slight decline of 0.13% the following day, indicating mixed investor sentiment.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, investors are cautiously optimistic about Labcorp's upcoming earnings, given its history of beating EPS estimates. However, the lack of specific guidance may lead to uncertainty.

Bull Case

If Labcorp continues its trend of beating EPS estimates, it could signal strong operational performance and lead to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet expectations or if there are signs of declining testing volumes, it could raise concerns about future growth and negatively impact the stock.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

Given Labcorp's history of beating EPS estimates, this figure will be crucial for investor confidence and stock performance.

How has testing volume changed compared to previous quarters?

Changes in testing volume can indicate market demand and operational efficiency, which are vital for future growth.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the impact of recent operational efficiencies that could drive higher-than-expected testing volumes.

Supporting Evidence

Labcorp has consistently beaten EPS estimates in the past, indicating strong management performance.

The options market is pricing in a larger move than historical averages, suggesting that investors are expecting significant news.

Recent insider buying suggests confidence in the company's future performance.

Key Risk

If testing volumes show unexpected growth, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance hinges on Labcorp's ability to maintain its growth trajectory while managing operational challenges.

Bull Confirmed If

An EPS of $4.50 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $4.00 could signal potential issues with growth and profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±10.59%

Historical Avg

±4.2%

Pricing rich

The options market is pricing in a significant move, suggesting that investors are expecting volatility around the earnings announcement.

Options are pricing ±10.6% while LH has averaged ±4.2% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

19.1%

Calls (600)P/C Ratio: 72.71Puts (300)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Labcorp beats expectations, history suggests a potential stock increase of around 1.95%, confirming strong operational performance.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a decline, with historical patterns suggesting a potential drop of around 4.18%.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

2 buys·0 sells

Members

House only

Est. Notional

$2,002.00–$30,000.00

disclosed dollar ranges

Most Active Members

D-MDApril McClain DelaneyRep.
2

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new testing technologies or services being introduced.
2Insights into changes in demand for specific types of tests.
3Management's outlook on the competitive landscape in the health care services sector.
4Comments on operational efficiencies and cost management strategies.
5Any guidance on future revenue growth or market expansion plans.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Domino's Pizza, Inc.

Company Snapshot

Labcorp Holdings Inc. is a leading health care company that provides laboratory services and diagnostic testing....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability, and investors will look for continued growth in this area.

N/A

Revenue Growth

Revenue growth is essential for assessing the company's ability to expand its market share and maintain profitability.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

LH Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+2.88%

Avg Stock Reaction

+1.95%

Last Quarter Recap

In Q1-2026, Labcorp reported an EPS of $4.25, exceeding expectations by 3.81%. However, the stock experienced a slight decline of 0.13% the following day, indicating mixed investor sentiment.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, investors are cautiously optimistic about Labcorp's upcoming earnings, given its history of beating EPS estimates. However, the lack of specific guidance may lead to uncertainty.

Bull Case

If Labcorp continues its trend of beating EPS estimates, it could signal strong operational performance and lead to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet expectations or if there are signs of declining testing volumes, it could raise concerns about future growth and negatively impact the stock.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

Given Labcorp's history of beating EPS estimates, this figure will be crucial for investor confidence and stock performance.

How has testing volume changed compared to previous quarters?

Changes in testing volume can indicate market demand and operational efficiency, which are vital for future growth.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the impact of recent operational efficiencies that could drive higher-than-expected testing volumes.

Supporting Evidence

Labcorp has consistently beaten EPS estimates in the past, indicating strong management performance.

The options market is pricing in a larger move than historical averages, suggesting that investors are expecting significant news.

Recent insider buying suggests confidence in the company's future performance.

Key Risk

If testing volumes show unexpected growth, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance hinges on Labcorp's ability to maintain its growth trajectory while managing operational challenges.

Bull Confirmed If

An EPS of $4.50 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $4.00 could signal potential issues with growth and profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±10.59%

Historical Avg

±4.2%

Pricing rich

The options market is pricing in a significant move, suggesting that investors are expecting volatility around the earnings announcement.

Options are pricing ±10.6% while LH has averaged ±4.2% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

19.1%

Calls (600)P/C Ratio: 72.71Puts (300)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Labcorp beats expectations, history suggests a potential stock increase of around 1.95%, confirming strong operational performance.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a decline, with historical patterns suggesting a potential drop of around 4.18%.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

2 buys·0 sells

Members

House only

Est. Notional

$2,002.00–$30,000.00

disclosed dollar ranges

Most Active Members

D-MDApril McClain DelaneyRep.
2

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new testing technologies or services being introduced.
2Insights into changes in demand for specific types of tests.
3Management's outlook on the competitive landscape in the health care services sector.
4Comments on operational efficiencies and cost management strategies.
5Any guidance on future revenue growth or market expansion plans.